Analysis Of Income And Expense [Abstract]

BioGaia - Filing #679336

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	—	—	—	—	1 296 506 SEK	—	—	—	—	—	—	1 103 957 SEK	—	—	—
Material income and expense [abstract]
Research and development expense	—	—	—	—	106 776 SEK	—	—	—	—	—	—	106 805 SEK	—	—	—
Finance income (cost)	—	—	—	—	25 731 SEK	—	—	—	—	—	—	8 6 15 4 SEK	—	—	—
Sales and marketing expense	—	—	—	—	363 256 SEK	—	—	—	—	—	—	320 798 SEK	—	—	—
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	—	—	—	9 762 SEK	—	9 762 SEK	9 762 SEK	—	—	25 722 SEK	25 722 SEK	25 722 SEK	—	—
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	0 SEK	0 SEK	3 65 3 52 SEK	0 SEK	355 590 SEK	0 SEK	3 55 59 0 SEK	9 762 SEK	0 SEK	0 SEK	399 495 SEK	399 495 SEK	2 5 27 2 SEK	373 773 SEK	0 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	—	—	—	—	355 590 SEK	—	—	—	—	—	—	399 495 SEK	—	—	—
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	—	—	—	—	- SEK	—	—	—	—	—	—	- SEK	—	—	—